COVID-19 Records

Gates Package — page 1358

of 1375 pages

← p.1357 p.1359 → · this page in the original PDF · package

@ DEVELOP ORAL BIOLOGICS Solving immune deficiencies How do we produce and deliver biologics into the gut such that they are stable, active, and durable? What will this contain? Potential platforms Deficient colostrum/ milk Scalable platforms that allow for production of low-cost, gut-directed interventions @ Adaptive immunity @ Innate immunity @ Human milk oligosaccharides Synthetic colostrum/ milk as a supplement to improve gut health of humans and animals @ Microbiome, cytokines, etc. PARTNERS: INCENTIVES: Regulatory measures/endpoints for approval of oral val af . *'MassBio' WENTALA BACTOLIFE -- antibody cocktails, price/ volume guarantees (to be developed) BIOSCIENCE LUMEN BIOSCIENGE G if Not for distribution

This is our OCR of the page, with running headers and footers removed. The Committee's PDF is authoritative; quote from it. Machine-readable, including the uncleaned text: /api/page/gates/1358

Records on this page

RecordDateTypePages
gates:exh:00637 attachment 1358